Uni-Bio Science Group Limited Announces 2025 Annual Results
- Written by Reporters
Record-Breaking Revenue of HK$586.2M and EPS Surged to HK$1.56 Cents
Dividends Distributed for Two Consecutive Years
Embarks on Innovation-Driven Transformation to Become a Global Pioneer in Regenerative Medicine
HONG KONG SAR - EQS Newswire - 27 March 2026 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bi...Read more: Uni-Bio Science Group Limited Announces 2025 Annual Results

